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Conclusion: The dosimetric accuracy of treatment plans 
calculated using a forced density technique is equivalent to 
planning on CT and does not appear to be a limiting factor 
for MRI only planning of brain patients. 
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Purpose or Objective: An MRI-only EBRT treatment planning 
workflow based on synthetic CTs (sCT) could help reduce 
MRI/CT registration uncertainties, while taking into account 
the improved soft tissue contrast of MRI for volumes 
definition, and reducing patient scanning time by avoiding 
the use of multiple imaging modalities for RT planning.  
The aim of this pilot study was to develop a model for 
creating sCTs for glioblastoma, based on commercial 
software and to further explore the potential of a low-field 
open MRI scanner dedicated to RT. 
 
Material and Methods: Using a clinical protocol optimized for 
RT planning T1 weighted MR (0.35T, Siemens Magnetom C!) 
and CT scans (Siemens Somatom Definition AS) were acquired 
for 6 patients with slice thickness of 4mm (MRI) and 2mm 
(CT). Target and OAR (brainstem, chiasm, cochlea, eye, 
hippocampus, lens and optic nerve) structures were 
delineated on MRI. The CTV was defined as the GTV 
(resection cavity) isotropically expanded by 1.5cm. For PTV 
the CTV was expanded by 0.5cm.  
Synthetic CTs were generated from the MRI by the 
commercial MriPlanner software (Spectronic Medical AB, 
Helsingborg, Sweden) utilizing the Statistical Decomposition 
Algorithm (Siversson et al, Med Phys. 2015; 42).  
The sCTs were tested for dosimetric validity compared to CT 
images. Delineated structures were transferred from MRI to 
CT via rigid image registration. For each patient a 6MV 
RapidArc plan was created on the CT using Eclipse (Varian 
Med. Sys.) and recalculated on the rigidly registered sCT 
using the same number of monitor units. The prescribed dose 
to D50% of the PTV was 60Gy in 30fx.  
 
Results: Visual comparison showed good agreement between 
CT and sCT. (Fig. 1) The slightly blurred appearance of the 
sCT is an effect of the lower slice resolution of the MRI 
compared to the CT. Dosimetric results are reported in Table 
1. 
 
 
 
 
 
Conclusion: In this pilot study the MriPlanner software, 
which was previously verified for prostate images acquired at 
higher field strengths, was uccessfully applied to 
glioblastoma cases.  
In the present study a patient fixation device was used for CT 
acquisition but not for MRI. This may lead to slight 
geometrical differences between CT and MRI, which may 
propagate to the dosimetric analysis. Nevertheless, the 
results of this study indicate that low-field MRI is suitable for 
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generating sCTs which could be used for EBRT treatment 
planning for glioblastoma. Additional improvements of MRI 
protocols and patient fixation may reduce dosimetric 
differences between CT and sCT even further. 
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Purpose or Objective: Publications have shown the benefit 
of motion compensation (MC) of 4D CT to create a mid-
position CT for planning of lung tumours. The MC process 
creates a single sharp image in which all information of the 
4D scan is combined, improving signal to noise ratio, while 
the absence of motion blurring improves the identification of 
tumour and organ-at risk boundaries compared to a maximum 
intensity or average scan. Furthermore, margins to account 
for the residual respiration motion relative to the mid-
position scan can be small. Unfortunately, there are as yet no 
commercial solutions available to create such scans and their 
use is limited to a few hospitals. The aim of this work is to 
apply two commercial deformable registration systems, 
combined with open source software, to create mid-position 
scans, and to evaluate their performance for potential 
clinical use. 
 
Material and Methods: 4D phase sorted CT scans (Philips 
Brilliance, 10 frames) of 8 patients were selected. Tumour 
peak to peak motion had to exceed 8 mm and there was no 
selection on scan quality. Deformable registration between 
all frames and the first was performed using Elekta’s Admire 
and Mirada’s RTx. The deformation vector fields (DVFs) were 
exported in DICOM format. Using the open source Conquest 
DICOM server, the DVFs and 4D CT were converted into Nifti 
format. A script in the DICOM server then called open source 
command tools of NiftyReg to first calculate the average 
DVF. Subsequently for each frame, the average DVF was 
subtracted from the frame DVF and the CT frame was 
deformed with this DVF to the mid-position. The resulting MC 
4D data was written out for analysis. To provide a measure of 
quality of the MC process, the overall standard deviation of 
the difference of each MC CT frame with the average MC CT 
was calculated. 
 
Results: The quality of the MC scans made with the two 
commercial systems is evaluated in Fig. 1 both quantitatively 
(frame by frame) and visually (average scans). Because post-
processing was identical for both systems, only the quality of 
the DVF affects the results. Overall there is very little 
performance difference between the systems, with the 
average residual SD for both systems being within one 
Hounsfield unit. It is furthermore visible that certain frames 
(particularly 1, 2, 7 and 10) have a larger residual. These lie 
between in- and exhale and show a higher motion speed of 
the anatomical structures leading, on average, to more 
blurring and artefacts. 
 
 
Conclusion: Using a combination of commercial and open 
source software, mid-position CT scans were created. The 
performance of both commercial deformable registration 
packages was similar. For some motion compensated frames, 
registration performance is poorer. For practical 
implementation of the mid-position scan in our clinic, we 
propose to exclude such frames, likely leading to a more 
robust performance. 
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Purpose or Objective: 7 Tesla (7T) MRI has recently shown 
great potential for high-resolution soft-tissue neuroimaging 
and visualization of micro-vascularisation in glioblastoma 
(GBM). Its value for the delineation of GBM in radiation 
